Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery



Status:Recruiting
Conditions:Cardiology, Neurology
Therapuetic Areas:Cardiology / Vascular Diseases, Neurology
Healthy:No
Age Range:18 - Any
Updated:4/17/2018
Start Date:May 2013
End Date:July 2020
Contact:Kate Brady
Email:kate.brady@phri.ca
Phone:905-527-4322

Use our guide to learn which trials are right for you!

Worldwide over 2 million adults (>30,000 Canadians) undergo heart surgery annually. Although
heart surgery provides important survival benefits, it is associated with potential major
complications such as death, stroke, and heart attack. There is promising evidence that
measurement of heart injury markers after surgery will identify patients at risk of death or
major complications.

This study will determine the current incidence of major complications in a representative
sample of 15,000 contemporary adult patients undergoing heart surgery. Knowing the current
burden of complications will inform clinicians, administrators, government and granting
agencies about resources required to address the problem. This study will also establish the
role of measuring heart injury markers to identify important heart injury after heart surgery
and the proportion that would go undetected without routine heart injury marker monitoring.
This information will facilitate further studies of timely interventions. In summary, the
VISION Cardiac Surgery Study addresses fundamental questions that will have profound public
health implications given the millions of adults worldwide who undergo heart surgery
annually.


Inclusion Criteria:

1. Age ≥ 18 years.

2. Patients who have undergone cardiac surgery. This includes coronary artery bypass
grafting and all open heart procedures such as valvular repairs/replacement.

Exclusion Criteria:

1. Previously enrolled in the VISION Cardiac Surgery Study.

2. Patients who have undergone an isolated pericardial window, pericardiectomy, permanent
pacemaker or defibrillator implantation.
We found this trial at
2
sites
Sydney, New South Wales
Principal Investigator: Graham Hillis, M.D
Phone: +61293362699
?
mi
from
Sydney,
Click here to add this to my saved trials
Los Angeles, California
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials